Hints and tips:
...SmithKline Beecham (now part of GSK) pulled its successful Lyme disease vaccine in the early 2000s amid rising anti-vaccine sentiment....
...I was an investor in Glaxo Wellcome and SmithKline Beecham through most of the 1990s, before their merger into one entity....
...That was what happened in the last big round of consolidation, around the turn of the millennium, through Glaxo Wellcome’s merger with SmithKline Beecham and Pfizer’s with Warner-Lambert and Wyeth....
...He notes that Allergan was spun out of SmithKline in 1989 when it merged with Beecham....
...In 1999, the ranking was BP, BT, Vodafone, HSBC and GlaxoSmithKline (Glaxo Wellcome only formally merged with SmithKline Beecham in 2000)....
...GSK, formed by a merger between Glaxo Wellcome and SmithKline Beecham in 2000, knows size alone is no cure-all....
...In 1999, Smithkline Beecham held a 29 per cent stake in the group. Quest’s laboratories provide test for cancers, cardiovascular diseases, thyroid disorders, and infectious diseases....
...Beecham in 1988....
...The company has evolved since Mr Garnier sparked a wave of industry consolidation in 2000, when he took SmithKline Beecham into what was then the UK’s largest merger, with Glaxo Wellcome....
...They gathered data to help make the case to the SmithKline board to fund their general adjuvant-based approach....
...Today, on Mr Yamada’s last day as head of research and development at GSK and a decade after he first became an employee of SmithKline Beecham, things look rather brighter....
...Ironically, before the merger, just as SmithKline Beecham had been a pioneer in offering discounted prices for vaccines in the developing world, so GlaxoWellcome was already offering substantial regional...
...Jean-Pierre Garnier recalls his concern when he took over as chief executive of GSK, following its creation from the merger of Glaxo Wellcome and SmithKline Beecham in 2000, and began to study in detail...
...GlaxoSmithKline has 9,000 US reps....
International Edition